High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients

Abstract MicroRNAs (miRs) are small non-coding RNA molecules, which are involved in the development of various malignancies, including prostate cancer (PCa). miR-17-5p is considered the most prominent member of the miR-17-92 cluster, with an essential regulatory function of fundamental cellular proc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Maria Jenvin Stoen, S. Andersen, M. Rakaee, M. I. Pedersen, L. M. Ingebriktsen, R. M. Bremnes, T. Donnem, A. P. G. Lombardi, T. K. Kilvaer, L. T. Busund, E. Richardsen
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/7720b93f13a84037a392d938fe35a950
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7720b93f13a84037a392d938fe35a950
record_format dspace
spelling oai:doaj.org-article:7720b93f13a84037a392d938fe35a9502021-12-02T16:14:55ZHigh expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients10.1038/s41598-021-93208-62045-2322https://doaj.org/article/7720b93f13a84037a392d938fe35a9502021-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-93208-6https://doaj.org/toc/2045-2322Abstract MicroRNAs (miRs) are small non-coding RNA molecules, which are involved in the development of various malignancies, including prostate cancer (PCa). miR-17-5p is considered the most prominent member of the miR-17-92 cluster, with an essential regulatory function of fundamental cellular processes. In many malignancies, up-regulation of miR-17-5p is associated with worse outcome. In PCa, miR-17-5p has been reported to increase cell proliferation and the risk of metastasis. In this study, prostatectomy specimens from 535 patients were collected. Tissue microarrays were constructed and in situ hybridization was performed, followed by scoring of miR-17-5p expression on different tumor compartments. High expression of miR-17-5p in tumor epithelium was associated with biochemical failure (BF, p < 0.001) and clinical failure (CF, p = 0.019). In multivariate analyses, high miR-17-5p expression in tumor epithelial cells was an independent negative prognostic factor for BF (HR 1.87, 95% CI 1.32–2.67, p < 0.001). In vitro analyses confirmed association between overexpression of miR-17-5p and proliferation, migration and invasion in prostate cancer cell lines (PC3 and DU145). In conclusion, our study suggests that a high cancer cell expression of miR-17-5p was an independent negative prognostic factor in PCa.Maria Jenvin StoenS. AndersenM. RakaeeM. I. PedersenL. M. IngebriktsenR. M. BremnesT. DonnemA. P. G. LombardiT. K. KilvaerL. T. BusundE. RichardsenNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Maria Jenvin Stoen
S. Andersen
M. Rakaee
M. I. Pedersen
L. M. Ingebriktsen
R. M. Bremnes
T. Donnem
A. P. G. Lombardi
T. K. Kilvaer
L. T. Busund
E. Richardsen
High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients
description Abstract MicroRNAs (miRs) are small non-coding RNA molecules, which are involved in the development of various malignancies, including prostate cancer (PCa). miR-17-5p is considered the most prominent member of the miR-17-92 cluster, with an essential regulatory function of fundamental cellular processes. In many malignancies, up-regulation of miR-17-5p is associated with worse outcome. In PCa, miR-17-5p has been reported to increase cell proliferation and the risk of metastasis. In this study, prostatectomy specimens from 535 patients were collected. Tissue microarrays were constructed and in situ hybridization was performed, followed by scoring of miR-17-5p expression on different tumor compartments. High expression of miR-17-5p in tumor epithelium was associated with biochemical failure (BF, p < 0.001) and clinical failure (CF, p = 0.019). In multivariate analyses, high miR-17-5p expression in tumor epithelial cells was an independent negative prognostic factor for BF (HR 1.87, 95% CI 1.32–2.67, p < 0.001). In vitro analyses confirmed association between overexpression of miR-17-5p and proliferation, migration and invasion in prostate cancer cell lines (PC3 and DU145). In conclusion, our study suggests that a high cancer cell expression of miR-17-5p was an independent negative prognostic factor in PCa.
format article
author Maria Jenvin Stoen
S. Andersen
M. Rakaee
M. I. Pedersen
L. M. Ingebriktsen
R. M. Bremnes
T. Donnem
A. P. G. Lombardi
T. K. Kilvaer
L. T. Busund
E. Richardsen
author_facet Maria Jenvin Stoen
S. Andersen
M. Rakaee
M. I. Pedersen
L. M. Ingebriktsen
R. M. Bremnes
T. Donnem
A. P. G. Lombardi
T. K. Kilvaer
L. T. Busund
E. Richardsen
author_sort Maria Jenvin Stoen
title High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients
title_short High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients
title_full High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients
title_fullStr High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients
title_full_unstemmed High expression of miR-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients
title_sort high expression of mir-17-5p in tumor epithelium is a predictor for poor prognosis for prostate cancer patients
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/7720b93f13a84037a392d938fe35a950
work_keys_str_mv AT mariajenvinstoen highexpressionofmir175pintumorepitheliumisapredictorforpoorprognosisforprostatecancerpatients
AT sandersen highexpressionofmir175pintumorepitheliumisapredictorforpoorprognosisforprostatecancerpatients
AT mrakaee highexpressionofmir175pintumorepitheliumisapredictorforpoorprognosisforprostatecancerpatients
AT mipedersen highexpressionofmir175pintumorepitheliumisapredictorforpoorprognosisforprostatecancerpatients
AT lmingebriktsen highexpressionofmir175pintumorepitheliumisapredictorforpoorprognosisforprostatecancerpatients
AT rmbremnes highexpressionofmir175pintumorepitheliumisapredictorforpoorprognosisforprostatecancerpatients
AT tdonnem highexpressionofmir175pintumorepitheliumisapredictorforpoorprognosisforprostatecancerpatients
AT apglombardi highexpressionofmir175pintumorepitheliumisapredictorforpoorprognosisforprostatecancerpatients
AT tkkilvaer highexpressionofmir175pintumorepitheliumisapredictorforpoorprognosisforprostatecancerpatients
AT ltbusund highexpressionofmir175pintumorepitheliumisapredictorforpoorprognosisforprostatecancerpatients
AT erichardsen highexpressionofmir175pintumorepitheliumisapredictorforpoorprognosisforprostatecancerpatients
_version_ 1718384298692706304